Shows & Panels
- AFCEA Answers
- Ask the CIO
- The Big Data Dilemma
- Carrying On with Continuity of Operations
- Connected Government
- Constituent Servicing
- Continuous Monitoring: Tools and Techniques for Trustworthy Government IT
- The Cyber Imperative
- Cyber Solutions for 2013 and Beyond
- The Data Privacy Imperative: Safeguarding Sensitive Data
- Expert Voices
- Federal Executive Forum
- Federal IT Challenge
- Federal Tech Talk
- Mission-critical Apps in the Cloud
- The Modern Federal Threat Landscape
- The Path from Legacy Systems
- The Real Deal on Digital Government
- The Reality of Continuous Monitoring... Is Your Agency Secure?
- Veterans in Private Sector: Making the Transition
Shows & Panels
Indianapolis pharmacy recalls compounded drugs
Tuesday - 4/23/2013, 11:38am EDT
INDIANAPOLIS (AP) -- A pharmacy that makes specialty medications is recalling nearly 100 compounded drugs after federal regulators found potential safety problems during an inspection.
Nora Apothecary Alternative Therapies of Indianapolis says it is recalling all sterile drugs that have not reached their expiration date. The drugs were made on or before April 19.
The company said it initiated the recall after the Food and Drug Administration found quality control problems that threaten the sterility of its products. If compounded drugs are not sterile they can cause infections, though the company said it has not received any reports of illness.
The FDA is conducting a wave of inspections at compounding pharmacies across the country. The action follows a deadly meningitis outbreak last year caused by contaminated drugs from a Massachusetts compounding pharmacy.
Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.